Buy Majesco, target Rs 715: HDFC Securities
Majesco is a smallcap company, operating in information technology sector.

Shares of Majesco traded at Rs 503 around 2:55 pm on 20 May, 2019. The brokerage has set a one-year horizon for the stock to hit the target price.
March quarter highlights:
- Revenue stood at $36.9 million, up 4.2 per cent QoQ, led by continued cloud traction (up 8.7 per cent QoQ, 44 per cent of revenue).
- Strong growth in cloud implementation (up 11.4 per cent QoQ, 32 per cent of revenue) is driven by Metlife deal which will go-live in Q2FY20. Successful implementation of MetLife deal is crucial as it will act as a reference for future wins.
- Cloud subscription, which is a high margin and annuity revenue stream, was up 47.5 per cent in FY19 (nearly 12 per cent to revenue). P&C/L&A revenue was up 5.4/2.1 per cent QoQ and contributed 68/31 per cent to revenue. For FY19, growth was fueled by L&A (up 51.4 per cent) while P&C was soft at 3.8 per cent.
- Ebitda margin contracted 354bps QoQ to 7.5 per cent due to one-time expenses. For FY19, margin expansion was healthy (up 662 bps) led by growth in cloud subscription. The 12-month executable order book was up 14 per cent YoY CC driven by cloud wins.
- Net Cash stands at Rs 389 crore against Rs 335 crore in FY18. The company is actively looking for an acquisition to strengthen its cloud offerings.
Investment rationale:
Huge shift has happened from on-premise to cloud model for the past two years. Cloud is now nearly 40 per cent of revenue and de-growth in legacy (nearly 20 per cent of rev) has started to stabilize, the brokerage said.
The partnership with Capgemini for L&A and Group life is a very positive development and can bring large deals on the table.
"We expect $revenue CAGR of 17 per cent over FY19-21E will be driven by cloud CAGR of 36 per cent and stable legacy. We maintain our positive stance on Majesco due to rising adoption of third-party software by insurers, IBM & Capgemini partnership, improving deal wins, and ramp-up in cloud revenues," the brokerage said.
However, slowdown in deal wins, increase in R&D and SG&A investments and global slowdown are the potential risks, the brokerage added.
Download ET Markets APP